These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2661700

  • 1. Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.
    Balsano F, Coccheri S, Libretti A, Nenci GG, Catalano M, Fortunato G, Grasselli S, Violi F, Hellemans H, Vanhove P.
    J Lab Clin Med; 1989 Jul; 114(1):84-91. PubMed ID: 2661700
    [Abstract] [Full Text] [Related]

  • 2. Ketanserin in intermittent claudication. A double-blind placebo-controlled study.
    Clement DL, Duprez D, Van Wassenhove A, Brusselmans F.
    Int Angiol; 1989 Jul; 8(2):92-6. PubMed ID: 2681451
    [Abstract] [Full Text] [Related]

  • 3. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG, Pini M, Moratti A, Paolicelli M, Basevi P, Quintavalla R, Manotti C, Di Lecce C.
    Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [Abstract] [Full Text] [Related]

  • 4. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Apr; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [Abstract] [Full Text] [Related]

  • 5. Effect of ketanserin in the treatment of patients with intermittent claudication: results from 13 placebo-controlled parallel group studies.
    Clement DL, Duprez D.
    J Cardiovasc Pharmacol; 1987 Apr; 10 Suppl 3():S89-95. PubMed ID: 2446082
    [Abstract] [Full Text] [Related]

  • 6. Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications.
    Thulesius O, Lundvall J, Kroese A, Stranden E, Hallböök T, Brunes L, Gjöres JE, Akesson H, Einarsson E, Ohlin P.
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):728-33. PubMed ID: 2442541
    [Abstract] [Full Text] [Related]

  • 7. Results of EMATAP: a double-blind placebo-controlled multicentre trial of ticlopidine in patients with peripheral arterial disease.
    Blanchard J, Carreras LO, Kindermans M.
    Nouv Rev Fr Hematol (1978); 1994 Jun; 35(6):523-8. PubMed ID: 8152898
    [Abstract] [Full Text] [Related]

  • 8. Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study.
    Castaño G, Más R, Gámez R, Fernández L, Illnait J.
    Angiology; 2004 Jun; 55(4):361-71. PubMed ID: 15258682
    [Abstract] [Full Text] [Related]

  • 9. Double-blind, controlled, multicenter study of indobufen versus placebo in patients with intermittent claudication.
    Tönnesen KH, Albuquerque P, Baitsch G, Gomez Alonso A, Ibanez F, Kester RC, Leveson S, Poredos P.
    Int Angiol; 1993 Dec; 12(4):371-7. PubMed ID: 8207316
    [Abstract] [Full Text] [Related]

  • 10. Hydrotherapy of patients with intermittent claudication: a novel approach to improve systolic ankle pressure and reduce symptoms.
    Elmståhl S, Lilja B, Bergqvist D, Brunkwall J.
    Int Angiol; 1995 Dec; 14(4):389-94. PubMed ID: 8708433
    [Abstract] [Full Text] [Related]

  • 11. [Padma-28, a herbal preparation, increases walking distance in patients with intermittent claudication].
    Drabaek H, Mehlsen J, Petersen JR, Himmelstrup H, Hansen KF.
    Ugeskr Laeger; 1994 Oct 17; 156(42):6207-9. PubMed ID: 7998359
    [Abstract] [Full Text] [Related]

  • 12. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E, Bahnini A, Mouren X, Gamand S.
    Int Angiol; 2001 Mar 17; 20(1):58-65. PubMed ID: 11342997
    [Abstract] [Full Text] [Related]

  • 13. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V, Mikhailidis DP, Barradas MA, Jeremy JY, Gracey L, Dandona P.
    Int J Clin Pharmacol Res; 1988 Mar 17; 8(5):377-81. PubMed ID: 3229875
    [Abstract] [Full Text] [Related]

  • 14. An evaluation of patients with severe intermittent claudication and the effect of treatment with naftidrofuryl.
    Moody AP, al-Khaffaf HS, Lehert P, Harris PL, Charlesworth D.
    J Cardiovasc Pharmacol; 1994 Mar 17; 23 Suppl 3():S44-7. PubMed ID: 7517477
    [Abstract] [Full Text] [Related]

  • 15. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Mar 17; 53 Suppl 1():S13-7. PubMed ID: 11865829
    [Abstract] [Full Text] [Related]

  • 16. The effects of physical training and flunarizine on walking capacity in intermittent claudication.
    Lepäntalo M, Sundberg S, Gordin A.
    Scand J Rehabil Med; 1984 Mar 17; 16(4):159-62. PubMed ID: 6397852
    [Abstract] [Full Text] [Related]

  • 17. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR, Dale RA, Creager MA, Lipicky RJ, Constant J, Campbell LA, Hiatt WR.
    Circulation; 2009 Jan 27; 119(3):452-8. PubMed ID: 19139383
    [Abstract] [Full Text] [Related]

  • 18. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC, Moher D, Barber GG.
    CMAJ; 1996 Oct 15; 155(8):1053-9. PubMed ID: 8873633
    [Abstract] [Full Text] [Related]

  • 19. A long-term study of policosanol in the treatment of intermittent claudication.
    Castaño G, Más Ferreiro R, Fernández L, Gámez R, Illnait J, Fernández C.
    Angiology; 2001 Feb 15; 52(2):115-25. PubMed ID: 11228084
    [Abstract] [Full Text] [Related]

  • 20. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG, Gresele P, Ferrari G, Santoro L, Gianese F, Mesoglycan Intermittent Claudication Group.
    Thromb Haemost; 2001 Nov 15; 86(5):1181-7. PubMed ID: 11816704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.